These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9218926)

  • 21. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.
    Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Bollinger P; Loor F
    Cancer Res; 1991 Aug; 51(16):4226-33. PubMed ID: 1678313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
    Pilarski LM; Yatscoff RW; Murphy GF; Belch AR
    Leukemia; 1998 Apr; 12(4):505-9. PubMed ID: 9557608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833.
    Liminga G; Nygren P; Larsson R
    Exp Cell Res; 1994 Jun; 212(2):291-6. PubMed ID: 7910563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin A and cyclosporin SDZ PSC 833 enhance anti-CD5 ricin A-chain immunotoxins in human leukemic T cells.
    Jaffrézou JP; Sikic BI; Laurent G
    Blood; 1994 Jan; 83(2):482-9. PubMed ID: 7506953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC-833 on colchicine and doxorubicin biliary secretion by the rat in vivo.
    Speeg KV; Maldonado AL
    Cancer Chemother Pharmacol; 1994; 34(2):133-6. PubMed ID: 7910787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
    Krishna R; Mayer LD
    Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents.
    Kreis W; Budman DR; Calabro A
    Cancer Chemother Pharmacol; 2001; 47(1):78-82. PubMed ID: 11221966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia.
    Bustamante J; Caldas Lopes E; Garcia M; Di Libero E; Alvarez E; Hajos SE
    Toxicol Appl Pharmacol; 2004 Aug; 199(1):44-51. PubMed ID: 15289089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446.
    Jachez B; Nordmann R; Loor F
    J Natl Cancer Inst; 1993 Mar; 85(6):478-83. PubMed ID: 8095304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic action of cyclosporins on human tumor cell lines is not dependent on immunosuppressive activity.
    Larssson R; Fridborg H; Csoka K; Bergh J; Nygren P
    Anticancer Res; 1992; 12(5):1581-5. PubMed ID: 1444225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the reversion of drug resistance in human cervical cancer cell lines].
    Chen H; Chen H; Wu X
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):669-71. PubMed ID: 11930693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic.
    Fridborg H; Jonsson E; Nygren P; Larsson R
    Eur J Cancer; 1999 Mar; 35(3):424-32. PubMed ID: 10448294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats.
    Lemaire M; Bruelisauer A; Guntz P; Sato H
    Cancer Chemother Pharmacol; 1996; 38(5):481-6. PubMed ID: 8765444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.
    Sonneveld P; Marie JP; Huisman C; Vekhoff A; Schoester M; Faussat AM; van Kapel J; Groenewegen A; Charnick S; Zittoun R; Löwenberg B
    Leukemia; 1996 Nov; 10(11):1741-50. PubMed ID: 8892677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
    Lehne G; Rugstad HE
    Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.
    Schwabe K; Steinheider G; Lawen A; Traber R; Hildebrandt A
    J Cancer Res Clin Oncol; 1995; 121(7):407-12. PubMed ID: 7635870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation.
    Cabot MC; Han TY; Giuliano AE
    FEBS Lett; 1998 Jul; 431(2):185-8. PubMed ID: 9708899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
    Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G
    Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.